Our Latest News - December 2023IRCM Newletter - December 2023

The IRCM's Sidney-Altman RNA Therapeutic Hub is Born

To kick off the holiday season, the IRCM is spreading hope and good news. Announced at its Foundation's Annual Gala, this major project carried out in collaboration with the Université de Montréal and major stakeholders will enable the development of promosing therapies.

En savoir plus

Tribute to Sidney Altman

The IRCM and its Foundation highlighted the scientific legacy of Dr. Sidney Altman, the 1989 chemistry Nobel Prize recipient for the discovery of the catalytic properties of RNA and a great Montrealer anchored in the scientific culture of the Institute. See video to learn more.

Hope For a Cure for Non-alcoholic Fatty Liver Disease

A concrete embodiment of the vitality of the IRCM Sidney-Altman RNA Therapeutic Hub, this work based on RNA inhibitors approach gives hope for a future cure.

Dr. Michel Cayouette, Recipient of a Research Recognition Award from the Université de Montréal

"Science bears the fruits of healing, and through collaboration with other research teams, we are determined to reap the benefits, for the benefit of patients' health," declared Dr. Cayouette.

An Important Mechanism of Immunity in Cancer is Unveiled

The study identified a previously unknown path that prevents phagocytosis, a mechanism that promotes the immune system's response to cancer.

Type 2 Diabetes: Killing Two Birds With One Stone

Reducing the incidence of type 2 diabetes as well as cardiovascular diseases are the two important objectives of a single promising approach.

Thesis defenses Congratulations

They Defended Their Thesis!

Congratulations to Sushmetha Mohan (supervised by Dr. Frédéric Charron), Ganesh Poorani Subramani (supervised by Dr. Javier Di Noia) and Weili Sun (supervised by Dr. Hua Gu) who successfully defended their doctoral thesis.


Every Monday at 11:30 a.m.: a Good Participation Rate

Thanks to the organizers of the January 2024 conferences (Drs. Marie Kmita, Woong-Kyung Suh, Jennifer Estall, Nicole Francis), the IRCM welcomes: Jörg Hermann Fritz, Christopher Rose and Wendy Bickmore. Thanks also to the team who make these weekly conferences possible!


A prosperous month for the IRCM's in the media, with coverage of several projects, the announcement of the IRCM's new Sidney-Altman RNA Therapeutic Hub, and news of the Foundation's Gala.

A complete report from Noovo about the RNA Hub (Thank you Drs Lécuyer and Sauvageau)

A myriad of reviews about the RNA Hub, including this one in L'actualité

Coverage in UdeMNouvelles (about the RNA Hub)

An outstanding gala (in Yahoo Finance)

Work by Dr. Nabil Seidah in La Presse

Making cancer vulnerable to the immune system by La Presse canadienne

Work by Dr. André Veillette in La Presse

Discovery of an antibody that stimulates the elimination of cancer by the immune system (UdeMNouvelles)

Work by Dr. May Faraj (UdeMNouvelles)

UdeM Recognition Prize for Dr. Michel Cayouette (UdeMNouvelles)

Work by Dr. Jennifer Estall (UdeMNouvelles)


Annual Gala: A Record Amount to Benefit Health Research

$815,000 were raised at the 2023 edition of the IRCM Foundation's Annual Gala which took place on November 28.

En savoir plus

It Pays to Donate Before the End of the Year!

Don't forget to make your donation before December 31, to be able to use your tax receipt for the year 2023.

En savoir plus


A Study on "Sugar Swings"

The Diabetes Clinic is looking for people living with type 1 diabetes (between 18 and 65 years old) to explore the link between variation in blood sugar variations, eating behaviors and brain functions that enable decision-making.


 

Instagram Facebook youtube Twitter Linkedin

 


 

Copyright © 2023
Institut de recherches cliniques de Montréal (IRCM)
Montreal Clinical Research Institute
All rights reserved.

Vous recevez ce courriel parce que vous vous êtes abonnés à l'infolettre, vous faites partie de la communauté interne de l'IRCM, vous avez fait un don à la Fondation de l'IRCM ou vous avez participé à un évènement organisé par l'IRCM. 




Envoyé par Yapla